3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Recurrence
1
Neoplasms
1
Lymphoma, Follicular
1
Depressive Disorder, Major
1
Brain Neoplasms
1
Interventions
Surgical Procedures, Operative
7
Liver Transplantation
5
Lenalidomide
4
Blood Specimen Collection
4
pomalidomide
3
Neoadjuvant Therapy
3
Liquid Biopsy
3
gilteritinib
2
Therapeutics
2
Rituximab
2
Proteasome Inhibitors
2
Observation
2
Mohs Surgery
2
Mitomycin
2
Magnetic Resonance Spectroscopy
2
Immunotherapy, Adoptive
2
Immunoconjugates
2
High-Throughput Nucleotide Sequencing
2
Fluorouracil
2
Drug Therapy
2
DNA, Mitochondrial
2
Brentuximab Vedotin
2
Bendamustine Hydrochloride
2
Antibodies, Monoclonal
2
Antibodies, Bispecific
2
Amplified Fragment Length Polymorphism Analysis
2
trametinib
1
romidepsin
1
nedaplatin
1
lenvatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Recurrence
×
Transcranial Magnetic Stimulation
×
Clear all
NCT01718730
2019-10-22
Cortical Excitability and Inhibition in MDD
Mayo Clinic
Completed
23 enrolled